Literature DB >> 14643809

A pressure overload model to track the molecular biology of heart failure.

Narain Moorjani1, Pedro Catarino, Raafat El-Sayed, Samaher Al-Ahmed, Brian Meyer, Futwan Al-Mohanna, Stephen Westaby.   

Abstract

OBJECTIVES: Pressure overload plays an important role in left ventricular remodelling and the development of heart failure. The underlying molecular mechanisms behind these processes are poorly understood at the myocyte level. To investigate this, we developed an ovine model of pressure overload-induced heart failure, in which serial left ventricular biopsies were obtained.
METHODS: Adult male sheep were chronically banded with a novel variable aortic constriction device. This was progressively inflated via a subcutaneous port to increase left ventricular afterload. The animals were monitored clinically and echocardiographically. Serial left ventricular endomyocardial biopsies were obtained via the right external carotid artery under fluoroscopic guidance. They were used to measure mRNA expression of the genetic regulators of apoptosis by reverse transcription polymerase chain reaction. In a subset of the animals, once left ventricular failure had been established, the constriction device was deflated to produce unloading of the left ventricle.
RESULTS: Ten of the 17 sheep banded developed left ventricular failure. Over the first 3-4 weeks, left ventricular mass index increased acutely (88+/-18 vs. 44+/-10 g/m(2), P<0.01) followed by gradual left ventricular dilatation (diastolic left ventricular internal diameter 4.1+/-0.7 vs. 3.2+/-0.3 cm, P<0.01). Ventricular function remained stable until 7-8 weeks postoperatively, when there was significant deterioration (fractional shortening 17+/-8 vs. 40+/-8%, P<0.01) associated with clinical heart failure. Expression of the pro-apoptotic genes (bax and Fas) increased significantly following inflation of the constriction device and persisted through the transition to left ventricular failure. Following deflation of the constriction device, myocardial contractility gradually improved over a 3 week period (fractional shortening 32+/-1 vs. 17+/-8%).
CONCLUSIONS: Progressively increasing the afterload on the left ventricle produces a clinical and echocardiographical picture of chronic heart failure. Obtaining myocardial tissue during this transition will allow the molecular correlates of pressure overload-induced heart failure and potential myocardial recovery to be investigated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14643809     DOI: 10.1016/s1010-7940(03)00514-1

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

Review 1.  Model-specific selection of molecular targets for heart failure gene therapy.

Authors:  Michael G Katz; Anthony S Fargnoli; Catherine E Tomasulo; Louella A Pritchette; Charles R Bridges
Journal:  J Gene Med       Date:  2011-10       Impact factor: 4.565

2.  Sheep can be used as animal model of regional myocardial remodeling and controllable work.

Authors:  Jürgen Duchenne; Piet Claus; Efstathios D Pagourelias; Razvan O Mada; Joeri Van Puyvelde; Kathleen Vunckx; Eric Verbeken; Olivier Gheysens; Filip Rega; Jens-Uwe Voigt
Journal:  Cardiol J       Date:  2018-03-23       Impact factor: 2.737

Review 3.  Animal Models to Study Cardiac Arrhythmias.

Authors:  Daniel J Blackwell; Jeffrey Schmeckpeper; Bjorn C Knollmann
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

Review 4.  Small and large animal models in cardiac contraction research: advantages and disadvantages.

Authors:  Nima Milani-Nejad; Paul M L Janssen
Journal:  Pharmacol Ther       Date:  2013-10-15       Impact factor: 12.310

5.  Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium.

Authors:  Bin Zeng; Guosheng Lin; Xiaofeng Ren; Yan Zhang; Honglei Chen
Journal:  J Biomed Sci       Date:  2010-10-07       Impact factor: 8.410

Review 6.  Preclinical models of congestive heart failure, advantages, and limitations for application in clinical practice.

Authors:  Marta Saura; Jose Luis Zamorano; Carlos Zaragoza
Journal:  Front Physiol       Date:  2022-08-04       Impact factor: 4.755

Review 7.  Large Animal Models of Heart Failure: A Translational Bridge to Clinical Success.

Authors:  Kleiton Augusto Santos Silva; Craig A Emter
Journal:  JACC Basic Transl Sci       Date:  2020-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.